Catching respiratory illnesses early is crucial to prevent their spread and get proper treatment. This study explored the potential of using wearable sensors and self-reported symptoms to prompt people to test themselves for common viruses at home. We found that this approach holds promise for early detection, but also identified areas for improvement before widespread use.
Quickly identifying respiratory infections like COVID-19 and RSV is key to controlling their spread. Traditionally, this involves visiting a doctor's office or clinic. However, a new approach is gaining traction: home testing. This study investigated whether wearable sensors and self-reported symptoms could trigger timely home testing for these viruses.
We conducted a decentralized, randomized controlled trial involving 450 participants in the US. Participants were randomly assigned to one of three groups:
Group 1: Received a wearable sensor (Fitbit Sense) and could be prompted to take home tests based on changes in their physiological data or self-reported symptoms.
Group 2: Received a wearable sensor and home tests, triggered only by symptoms.
Group 3: Control group with no wearable sensors or home tests.
The primary goal was to assess the feasibility of prompting home testing based on wearable data or symptoms and to measure how many participants actually used the home tests.
The trial successfully recruited and randomized participants.
Over half (52%) were from underrepresented groups in research.
Among those who received home tests (Groups 1 and 2), 39% were prompted to test.
More prompts were triggered by symptoms (68%) than wearable data (32%).
Out of those prompted, 52% successfully performed the home test.
Of those tested, 31% were positive for a virus (all SARS-CoV-2).
Notably, there were no adverse events related to the testing approach.
This study demonstrates the early feasibility of a program prompting home testing for respiratory viruses based on both symptoms and wearable data. However, areas for improvement were identified:
Wearable sensors need better refinement to trigger testing more effectively.
Strategies to increase participation rates in-home testing are necessary.
This study paves the way for utilizing wearable sensors and home testing to identify respiratory viruses. Further research will focus on optimizing technology and participant engagement to facilitate wider implementation of this promising approach.
Quer G, Coughlin E, Villacian J, et al. Feasibility of wearable sensor signals and self-reported symptoms to prompt at-home testing for acute respiratory viruses in the USA (DETECT-AHEAD): a decentralized, randomized controlled trial. Lancet Digit Health. 2024;6(8):e546-e554. doi:10.1016/S2589-7500(24)00096-7
1.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
2.
In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.
3.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
4.
AI tool automates liver tumor detection and monitoring
5.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
1.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Unlocking the Power of Cryoprecipitate: A Comprehensive Guide
4.
How Cancer Cells Evade Immune Destruction and the Fight Back
5.
Unlocking The Causes And Risk Factors Of Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation